Patent · US Active

Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

US11629150B2 · kind B2 · utility

0Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2020
Grant dateApr 18, 2023
Priority date
Expiry dateDec 14, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.